Allucent

Silver Sponsor

Allucent, formed from the recent merger of CATO SMS and Pharm-Olam, is a global clinical services organization uniquely positioned to serve small and mid-sized biotech companies. With more than 30 years of experience in over 60 countries, we have supported over 200 rare and orphan disease clinical studies across a variety of novel therapy classes and precision medicine including; gene therapies, GMO’s, stem cell therapies, and mRNA and antisense therapies. With an integrated approach encompassing regulatory, clinical, and scientific expertise, we’re adept at overcoming the challenges of delivering novel treatments to patients.

website

Get Involved At World Orphan Drug Congress USA

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Claire Murphy
claire.murphy@terrapinn.com
t/ +1 646 619 1784

 

 

 

Marketing & Press Opportunities

 
 

Taylor Post 
taylor.post@terrapinn.com
t/ +1 646 619 1785